Bayer receives positive CHMP opinion for its hemophilia A treatment BAY94-9027

The safety and efficacy profile of BAY94-9027 has been demonstrated in more than five years of clinical studies / Prophylaxis with BAY94-9027 enables sustained factor VIII concentrations in the blood over time ...

Bayer’s Jivi® approved in Japan for hemophilia A

Bayer announces Care4Cattle grant recipients in celebration of advancing cattle well-being

Three projects to receive Care4Cattle grants for innovations in advancing the well-being of cattle / Care4Cattle received over 100 entries across 37 countries, with winners selected from Australia, Brazil and the United Kingdom ...

Bayer collaborates with One Acre Fund to support smallholders in Africa with a donation of EUR 700,000

Project aims to improve African smallholder farmers’ incomes and enable better nutrition for their families / The long-term goal is to establish a joint network with social entrepreneurs and thus sustainably improve the lives of smallholder farmers in rural regions of Africa ...

Future of Farming Dialogue 2018

Bayer outlines its vision for the future of agriculture

Company focused on innovation, sustainability and digital transformation for the benefit of farmers, consumers and the planet ...

Bayer supports rebuild after severe floods

EUR 124,000 in emergency aid provided to farmers in Shandong and Jiangsu provinces ...

Next generation of agricultural talent invited to ‘plant their path’ at the 2019 Youth Ag Summit in Brazil

Applications are now open until January 10, 2019 ...

Experts unite to address fatal angiostrongylosis bleeding disorders

Angiostrongylus vasorum is a growing threat to dogs, with the disease spreading to new areas and growing to endemic status in established areas ...

Stefan Oelrich to join Bayer Board of Management and head Pharmaceuticals Division

Dieter Weinand leaving the company as of November 1, 2018 / Contract extensions for Board of Management members Liam Condon and Dr. Hartmut Klusik ...